HiSiaddi is an innovative foreign trade service provider driven by both technology transformation and export business. It has established a service system of "1+2+3+4=1" and can supply D-mannose sourced directly from multiple well-known brand manufacturers.
As a foreign trade enterprise with R&D capabilities, HiSiaddi has conducted multiple rounds of on-site inspections of D-mannose manufacturers relying on technological cooperation with factories, possessing objective and in-depth understanding of different brands. The company regularly analyzes various D-mannose manufacturers for clients to help them select suitable products. Below is a brand recommendation case.
For more comparative analysis of brands and models, please contact HiSiaddi customer service.
The purchaser is NaturHealth Australia Pty Ltd based in Sydney, Australia, a leading mid-to-high-end dietary supplement brand in Australia. Its products are sold at premium retail channels including Woolworths high-end organic zones across Australia, Priceline chain beauty pharmacies, and Countdown boutique health supermarkets in New Zealand. The company’s three core products are urinary care sustained-release hard capsules, organic pure powder reconstituted drinks, and low-temperature nutrient solutions for infants. All product lines comply with Australia’s TGA pharmaceutical raw material access specifications, U.S. USP Pharmacopoeia, FCC food standards, and dual USDA Organic & Kosher certifications, with stable annual D-mannose procurement of 96 tons divided into three differentiated specifications. The brand previously purchased pharmaceutical-grade raw materials from Europe for years. Affected by rising international raw material prices and unstable ocean shipping lead times, it planned a full switch to raw materials sourced from domestic Chinese manufacturers, making it a high-quality client with strict requirements for raw material indicators, production processes, and certification qualifications.
During initial domestic raw material screening, the client independently contacted four leading domestic D-mannose manufacturers: Shandong Luwei Pharmaceutical, Hebei HuXu Pharmaceutical, Inner Mongolia Changhui Bio, and Zhejiang Shengge Bio. All four manufacturers hold export qualifications for Europe and America without maliciously disparaging competitors, yet constrained by sales-oriented targets, each manufacturer only highlighted advantages of its own product lines and promoted its own models, avoiding objective elaboration of competitors’ product strengths, applicable scenarios, and shortcomings. The client received four completely different product recommendation schemes with inconsistent purity, preparation processes, powder specifications, and quotations. Small samples were purchased from each manufacturer for pilot production testing, resulting in successive failures: delayed capsule disintegration for partial raw materials, moisture absorption & caking of powders, and crystal precipitation of infant nutrient solutions under low-temperature storage. All four batches of samples failed to match the client’s formulation system, stalling raw material selection. Lacking a domestic D-mannose brand database, the client could not distinguish differences between standard and high-end customized models of each brand and conduct independent horizontal comparison of pros and cons. It formally entrusted HiSiaddi, as a neutral third party, to horizontally dissect product parameters of mainstream domestic brands, objectively sort out advantages and disadvantages of core models from four manufacturers, and select matching brands and product specifications aligned with terminal formulation requirements.
HiSiaddi conducted on-site factory visits to all four manufacturers and sampled physical and chemical testing of core models via a CNAS-certified third-party laboratory, breaking away from manufacturers’ self-promotional rhetoric to objectively sort out full product lines of four leading brands across eight dimensions: raw material preparation process, purity range, powder physical properties, impurity control, certification system, applicable product dosage forms, price, and defects.
Three core mainstream models: ① Standard food-grade D98 powder (HPLC 98.0%); ② USP pharmaceutical high-purity D99.5 fine powder; ③ Sustained-release specialized classified crystalline particles D99.2. Brand Advantages: Full-chain enzymatic conversion mass production process with annual production capacity of 4,000 tons, stable mass shipment delivery. Complete FDA GRAS, EU REACH, USP compliance filings. Excellent control of single impurity sugars (glucose, fructose) in high-purity grades, especially suitable for capsule tableting systems. Objective Shortcomings: Limited customized production capacity for beech wood hydrolysis products; standard granulated models lack organic certification; fine powder models feature high moisture absorption, unsuitable for pure powder formulations without auxiliary materials. Applicable Scenarios: Pharmaceutical sustained-release capsules, ordinary functional beverages.
Core models: ① National standard D98 standard powder; ② Beech wood plant-extracted high-purity D99.6 powder; ③ Low-temperature anhydrous granulated organic particles D99.3. Brand Advantages: One of the few domestic manufacturers with stable mass production capacity for beech wood hydrolysis mannose, mature granulation workshop processes with excellent finished particle flowability and moisture ≤0.18%. Full product lines can be supported with USDA Organic traceability documents, and residual impurity alcohol control outperforms industry averages with strong low-temperature liquid stability. Objective Shortcomings: Long lead time for small-batch customized pharmaceutical classified crystals; unit price for large-tonnage bulk procurement higher than Luwei; limited stock of capsule-specific crystal form products. Applicable Scenarios: Organic powders, infant low-temperature oral liquids.
Core models: Plant-derived D98.5 fully water-soluble powder, compound blended mannose powder (blended with erythritol). Brand Advantages: Self-owned plant planting bases with mature natural extraction routes, cost-effective blended formulations, flexible small-batch order acceptance. Objective Shortcomings: No mass production lines for USP 99.5+ high-purity monomers; no capsule-specific classified crystalline products; high-purity raw materials require outsourced processing, unable to meet the client’s clean label requirement of no additives. Applicable Scenarios: Ordinary compound solid beverages, affordable compound health products; incompatible with the client’s high-end organic single-ingredient formulations.
Core models: D98 food grade, customized ultra-fine water-soluble powder. Brand Advantages: Mature ultra-fine powder crushing technology with adjustable particle size on demand, fast warehousing and delivery from southern China. Objective Shortcomings: Insufficient large-scale high-purity pharmaceutical production capacity; independent granulation and crystal screening production lines unavailable; mass order capacity under pressure; no complete TGA, USP supporting test reports. Applicable Scenarios: Ordinary liquid beverages, incompatible with capsule and high-end organic powder requirements.
Mandatory requirements for the client’s three products: ① Sustained-release capsules (USP99.5 high purity, stable crystal forms, disintegration compliant with Australia TGA standards); ② Organic single-ingredient powders (beech wood source, anhydrous granulation, no external auxiliary materials, no moisture absorption & caking under normal temperature storage); ③ Infant acidic nutrient solutions (stable weak acid compatibility, no crystal precipitation under low temperature, low impurity sugar content). After comprehensive evaluation of advantages and disadvantages of four manufacturers, Inner Mongolia Changhui and Zhejiang Shengge were eliminated as their product specifications and processes could not cover high-end requirements of the three production lines. Two mid-to-high-end brands – Shandong Luwei and Hebei HuXu – were finalized with three precise customized models corresponding one-to-one to the client’s terminal formulations:
USP high-purity D99.5 classified crystalline powder: High-purity enzymatic purification of raw materials with individual glucose and fructose impurities ≤0.08%, stable crystal forms screened with precise 80~120 mesh classification, reasonable porosity post-filling to completely resolve excessive capsule disintegration time. Complete TGA, USP bilingual COAs support Australian pharmaceutical warehouse audit review.
1. Organic anhydrous granulated D99.3 particles: Beech wood plant hydrolysis raw materials, auxiliary-free full granulation process with strictly controlled moisture of 0.17%, excellent particle repose angle, no caking of client’s pure powder packaging after 90 days of normal temperature storage, complete USDA Organic full-chain traceability.
2. Beech wood high-purity D99.6 ultra-fine water-soluble powder: Multi-stage ion exchange to remove impurity sugars and residual solvents, stable solubility in weak acid environments with no crystal precipitation after 120 days of 4℃ refrigeration, compatible with infant nutrient solution systems at pH ~3.5.
HiSiaddi coordinated sample delivery from two manufacturers in phases: 500g laboratory samples → 50kg pilot raw materials → 500kg mass production trial orders. The client’s Australian R&D laboratory completed formulation accelerated stability tests and continuous trial production on its own production lines: Luwei crystalline raw materials achieved capsule disintegration within the interval specified by TGA; HuXu granulated powders showed no caking and liquid raw materials had no precipitation throughout refrigeration storage, with all three products fully passing third-party authoritative testing in Australia.
The client formally signed an annual framework order of 96 tons with raw material breakdown as follows: 41 tons of Luwei D99.5 crystalline materials (exclusive for sustained-release capsules), 32 tons of HuXu granulated particles (organic powders), and 23 tons of HuXu ultra-fine water-soluble powder (infant nutrient solutions), scheduled monthly across 12 balanced batches throughout the year. HiSiaddi simultaneously assisted both manufacturers in sorting Australia TGA raw material filing materials, USP English quality inspection certificates, organic origin traceability documents, and supplementary Kosher certification files delivered with each shipment to guarantee Australian customs clearance and product listing compliance.
Building on this accurate model selection project, the client later expanded into high-end organic markets in New Zealand and Malaysia, fully entrusting HiSiaddi with all D-mannose raw material procurement and preliminary brand screening work, raising total annual procurement volume to 121 tons the following year.
Neutral model selection by HiSiaddi helped the client avoid marketing traps from single-brand manufacturers, reducing raw material procurement costs by 26% compared with European imports. Three high-end organic new products were successfully launched across premium supermarkets in Australia and New Zealand, forming stable product quality via matched raw materials with terminal product premiums higher than similar market products, completely eliminating loss costs from repeated sampling and raw material scrappage. Supported by the brand product archive issued by HiSiaddi, the client built its own raw material incoming inspection standards for rapid independent brand screening in subsequent monosaccharide procurement.
Luwei and HuXu refined product documentation systems aligned with Australia and New Zealand TGA regulations via this high-end Australian order, securing fixed procurement orders from multiple nutrition brands in New Zealand and Singapore relying on this successful project case, further expanding overseas high-end markets.
Breaking away from the traditional foreign trade model relying solely on single-manufacturer commission, HiSiaddi eliminated industry information barriers of "manufacturers only promote their own products and avoid elaborating competitors’ strengths" via neutral third-party brand evaluation capabilities. Differentiated full-link service advantages covering preliminary raw material selection, sample follow-up, and compliance support were formed to secure high-quality long-term overseas mid-to-high-end clients.
Constrained by performance targets, leading domestic D-mannose manufacturers prioritize highlighting advantages of their own products during promotion and do not voluntarily conduct objective analysis of competitors’ strengths and their own product shortcomings. Mid-to-high-end dietary brands in Europe, Australia, and New Zealand feature refined product formulations and strict national access regulations, with minor differences in raw material purity, processes, and particle size capable of triggering mass production failures. Supported by a complete domestic raw material brand database, HiSiaddi conducts objective horizontal comparison and model selection to precisely match client terminal product requirements, filling brand information gaps between Chinese and foreign supply and demand sides and serving as a critical bridge for overseas high-end clients switching to domestically sourced raw materials.
For more comparative analysis of brands and models, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
